tradingkey.logo

BRIEF-Myriad Genetics Announces Two New Patents Granted For Its Molecular Residual Disease (MRD) Assay

ReutersFeb 5, 2025 9:22 PM

- Myriad Genetics Inc MYGN.O:

  • MYRIAD GENETICS ANNOUNCES TWO NEW PATENTS GRANTED FOR ITS MOLECULAR RESIDUAL DISEASE (MRD) ASSAY

Source text: ID:nGNX20YtBb

Further company coverage: MYGN.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI